Symptomatic oxygen for non-hypoxaemic chronic obstructive pulmonary disease.

@article{Uronis2011SymptomaticOF,
  title={Symptomatic oxygen for non-hypoxaemic chronic obstructive pulmonary disease.},
  author={Hope Elizabeth Uronis and Douglas C. McCrory and Gregory P Samsa and David Christopher Currow and Amy Abernethy},
  journal={The Cochrane database of systematic reviews},
  year={2011},
  volume={6},
  pages={CD006429}
}
BACKGROUND Dyspnoea is a common symptom in chronic obstructive pulmonary disease (COPD). People who are hypoxaemic may be given long-term oxygen relief therapy (LTOT) to improve their life expectancy and quality of life. However, the symptomatic benefit of home oxygen therapy in mildly or non-hypoxaemic people with COPD with dyspnoea who do not meet international funding criteria for LTOT (PaO(2)< 55 mmHg or other special cases) is unknown. OBJECTIVES To determine the efficacy of oxygen… CONTINUE READING